STAT3 and neoplasm: The transcription factor STAT3 is frequently activated in a variety of malignancies and emerging data points toward STAT3-mediated upregulation of OXPHOS as a mechanism of survival in drug-resistant tumours and a potential marker for drugs targeting mitochondrial metabolism [36–38].